Intrathecal Dexmedetomidine

3

Review clinical trials related to Intrathecal Dexmedetomidine. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Intrathecal Dexmedetomidine With Bupivacaine, in Patients Undergoing Knee Orthopedic Surgery

This study aims to compare the duration of analgesia (as the primary outcome) and adverse effects (as the secondary outcome) after intrathecal administration of dexmedetomidine with hyperbaric bupivacaine to patients undergoing knee orthopedic surgery.

Participants needed: 120
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Cairo UniversityUpdated: Apr 13, 2026Locations: 1
Eligibility criteria

Age from 18 to 65 years. [+2]

Patients with psychiatric disorders. [+4]

Status: Recruiting

Transversalis Fascia Plane Block Versus Intrathecal Dexmedetomidine in Patients Undergoing Cesarean Section

This study aims to compare the analgesic efficacy of the transversalis fascia plane (TFP) block and intrathecal dexmedetomidine in patients undergoing cesarean section (CS).

Participants needed: 50
Trial details
Age: 18-40Biological sex: FemaleType: InterventionalSponsor: Tanta UniversityUpdated: Sep 16, 2025Locations: 1
Eligibility criteria

Age from 18 to 40 years. [+2]

Contraindication to spinal anesthesia. [+10]

Status: Recruiting

Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia After Total Knee Arthroplasty

The aim of this work is to evaluate the effect of combined intrathecal dexmedetomidine and adductor canal block for analgesia after total knee arthroplasty (TKA).

Participants needed: 75
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Kafrelsheikh UniversityUpdated: Feb 21, 2025Locations: 1
Eligibility criteria

Age from 18 to 75 years. [+3]

Patients with neurological or intellectual disability. [+6]